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Hitting the target: fragment screening with acoustic
in situ co-crystallization of proteins plus fragment
libraries on pin-mounted data-collection
micromeshes
Acoustic droplet ejection (ADE) is a powerful technology
that supports crystallographic applications such as growing,
improving and manipulating protein crystals. A fragmentscreening strategy is described that uses ADE to co-crystallize
proteins with fragment libraries directly on MiTeGen MicroMeshes. Co-crystallization trials can be prepared rapidly and
economically. The high speed of specimen preparation and the
low consumption of fragment and protein allow the use of
individual rather than pooled fragments. The Echo 550 liquidhandling instrument (Labcyte Inc., Sunnyvale, California,
USA) generates droplets with accurate trajectories, which
allows multiple co-crystallization experiments to be discretely
positioned on a single data-collection micromesh. This
accuracy also allows all components to be transferred through
small apertures. Consequently, the crystallization tray is in
equilibrium with the reservoir before, during and after the
transfer of protein, precipitant and fragment to the micromesh
on which crystallization will occur. This strict control of the
specimen environment means that the crystallography experiments remain identical as the working volumes are decreased
from the few microlitres level to the few nanolitres level.
Using this system, lysozyme, thermolysin, trypsin and stachydrine demethylase crystals were co-crystallized with a small
33-compound mini-library to search for fragment hits. This
technology pushes towards a much faster, more automated
and more flexible strategy for structure-based drug discovery
using as little as 2.5 nl of each major component.

Received 2 September 2013
Accepted 24 December 2013

PDB references: thermolysin,
4m65; trypsin, 4ncy;
lysozyme, 4n8z

1. Introduction
Structure-based drug discovery using X-ray crystallography as
a primary fragment-screening tool (Chilingaryan et al., 2012)
allows simultaneous structural characterization of each
binding site, including allosteric sites (Bauman et al., 2013),
and the immediate capacity to improve the potency or pharmaceutical characteristics of the fragment hit (Edwards et al.,
2007). Fragment strategies attempt to screen a low-molecularweight library and subsequently improve the initial hit to
achieve a tight-binding lead compound (Erlanson et al., 2004).
In co-crystallization searches, the consumption of 1–10 mg
protein and 100 nl of chemical per screened condition has
been reported (Klages et al., 2007; Rich & Myszka, 2004;
Erlanson et al., 2004). The optimum throughput for the
acquisition of X-ray data is 1 min per screened fragment
(limited by the maximum speed of robotic automounters;
Cork et al., 2006), while a realistic throughput is a slower
4 min per screened condition (Wasserman et al., 2011).
Crystallization is often automated, but crystal harvesting is
frequently manual and laborious, although it can also be
automated (Cipriani et al., 2012; Soares et al., 2011; Viola et al.,
doi:10.1107/S1399004713034603

1177

research papers
2007). The throughput rate can be increased by grouping
fragments into cocktails of chemically compatible compounds,
which are often structurally diverse to facilitate identification
in the electron density (non-diverse compounds may be used
in some cases; Nicholls et al., 2010). When a binding event is
observed, the cocktail is deconvoluted either using the electron density or by individually screening each cocktail
member during a second-pass experiment (Spurlino, 2011).
Existing fragment-screening strategies work well in commercial applications, where the cost of fragment libraries and the
availability of purified protein are not limiting factors.
However, the resource boundaries that constrain most
academic efforts will not stretch enough to screen a typical
2000-fragment library using 1 ml protein and 4 min of
synchrotron beam time per specimen. A faster and more
efficient strategy is needed.
Here, we report a fully automated system for using acoustic
droplet ejection to co-crystallize a protein of interest with a
fragment library using 2.5–40 nl purified protein (0.025–
0.400 mg at 10 mg ml1) and 2.5–10 nl fragment compound
per screened condition. Crystals are grown directly on datacollection media, such as MiTeGen MicroMeshes, and consequently no looping or mounting is needed. The specimen
preparation rate is 60 per minute (including protein, precipitant and fragment). Using a conventional cryogenic automounter system, a shutter-less data-acquisition rate of ten

Figure 1
Acoustic droplet ejection. Acoustic droplet ejection (ADE) uses sound
energy to transfer variable micro-droplets (e.g. nanolitres or picolitres) of
solution (protein, precipitant, fragments etc.) from a crystallization well,
through a short air column (1 cm) to data-collection media. Soundwave energy from the transducer is channeled to the focal point (i.e.
ejection zone), displacing the surface where a controlled ejection occurs.
Droplet size is governed by the wavelength of the sound emitted and this
proportionality yields accurate ejected volumes. In this work, an Echo 550
liquid handler was used to co-crystallize proteins, precipitants and
fragments in situ directly on MiTeGen MicroMeshes by vapour diffusion.
The Echo 550 does not use frequency changes to transfer different
volumes. Instead, it uses a fixed-frequency sound pulse to transfer each
component in 2.5 nl increments.
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screened conditions per minute is achieved by positioning
multiple crystal and fragment pairs on each data-collection
micromesh (so that each robotic automounter cycle inserts ten
discrete experimental conditions for testing). This sustained
rate of ten screened conditions per minute will approach the
maximum data-acquisition speed that can be supported by the
available X-ray intensity at third-generation synchrotrons. For
example, if the full NSLS II X-ray fan is focused into a 20 mm
square beam at the AMX beamline (currently under
construction), protein crystals will be fully exposed to their
radiation-dose limit (2  107 Gy) in 2 s (Hodgson et al., 2009).
This high rate of sustained data acquisition will allow structurebased fragment screening without having to group chemicals
into cocktails, thus mitigating the effects of a high aggregate
fragment concentration on protein stability and crystallization
(Boyd & Kloe, 2010; Baurin et al., 2004), avoiding the possibility of inter-fragment interactions (Drinkwater et al., 2010;
Nair et al., 2012) and avoiding the need for a deconvolution
strategy to differentiate between the fragments in each cocktail (Nicholls et al., 2010).
Acoustic droplet ejection (ADE) has a demonstrated utility
for growing protein crystals (Villaseñor et al., 2012), improving
the quality of protein crystals (Villaseñor et al., 2010) and
manipulating protein crystals (Soares et al., 2011). This method
uses a sound pulse to transfer momentum to a liquid (or
suspended solid). The liquid is then propelled out of the
source location, through a short air column and onto an
arbitrary destination (Ellson et al., 2003; Fig. 1) with a
published volumetric accuracy of 5% and a measured trajectory precision of 1.3 (data not shown; larger for some fluids).
The high trajectory accuracy enables a ‘drop-on-drop’
capability which supports the combination of distinct
components from different source wells onto the same destination location. Our group has demonstrated that a high
‘drop-on-drop’ accuracy is sustained across a wide variety of
commercially available crystallization conditions and cryoprotectants (Cuttitta et al., 2014). The transferred volume of
the liquid is governed by the frequency of the sound (a typical
working volume is 2.5 nl), and the velocity is determined by
the amplitude of the sound (a typical ejection velocity is
1 m s1). To eject larger volumes, the Echo 550 liquid-handling
instrument does not modulate the frequency of the sound, but
rather emits multiple sound pulses to build up the desired
volume in 2.5 nl increments.
Villasenor and coworkers have suggested that acoustic
methods might be used for structure-based drug discovery by
co-crystallizing proteins and fragments using a shared reservoir on a conventional crystallization plate (Villaseñor et al.,
2012). Acoustic methods are an attractive choice for microcrystallization for several reasons. ADE is an automated
technique that is independent of operator skill. It is physically
gentle, with no tips or tubes that may leach chemicals, cause
cross-contamination between specimens (McDonald et al.,
2008) or damage crystals. Transfers have high accuracy even at
very low volume (2.5 nl), with zero loss of specimen since
there are no tips or tubes that liquids can adhere to (zero lost
volume per transfer). The inaccessible volume at the bottom
Acta Cryst. (2014). D70, 1177–1189
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of each well is very small (4 ml dead volume; Harris et al., 2008)
and can readily be reduced even further (Cuttitta et al., 2014).
Specimen transfer is fast (2.33  0.04 mounts per second to
multiple destinations, 500 mounts per second between fixed
locations; data not shown), which reduces specimen preparation time, and consequently also reduces the time during
which specimens are exposed to atmospheric dehydration.
Dehydration effects can be virtually eliminated by transferring
all proteins, precipitants and fragment components through
small apertures in the destination plate (called the pin platform box; see x2.1). Apertures can also be used in the source
plate. Fragments solvated in DMSO are hygroscopic and will
rapidly swell with incorporated water when exposed to
atmospheric humidity. This problem is prevented by keeping
the source plate covered with a plastic seal and by transferring
DMSO-solvated fragments through apertures in the plastic
seal.
When crystals are grown directly on data-collection media
and robotically cryocooled, all steps in the fragment-screening
process become fully automated. One consequence of full
automation is that all metadata are machine-generated and
can potentially be automatically deposited into a common
database. Robust integration of automated specimen
preparation with the X-ray data-acquisition database will
facilitate implementation of a workflow-management program
to simplify complex drug-discovery projects (Tsai et al., 2013).
Conveniently, no time is wasted on laboriously fishing protein
crystals out of hanging or sitting drops. The equipment is
operated through an intuitive GUI with minimal training. The
entire fragment-library screening process is keyboard-driven
and compatible with remote operation. As an illustration of
the robust simplicity of this system, the experimental work for
this project was largely performed by a team of diligent
undergraduate students during a ten-week summer internship
program.

between the protein and the precipitant. To avoid dehydration, components were usually added to the pin platform box
through small apertures in the lid after the box had been
sealed and equilibrated against the precipitant. Similarly,
excess mother liquor can be removed through the bottom of
the micromesh using apertures in the pin platform window.
The apertures are covered with conventional tape unless
material is being added or removed from the micromeshes. At
present, we make apertures by hand using a heated metallic
probe (30 min per tray), so apertures were not used for
proteins that did not easily precipitate (lysozyme and thermolysin).
2.1. In situ crystallization on micromeshes secured in pin
platform boxes

To demonstrate the capability of the Echo 550 to cocrystallize a protein of interest and a fragment library in situ
directly on data-collection media, we first determined

2. Methods
Our approach relies on a custom-designed destination plate
called a ‘pin platform box’ (Fig. 2). This box allows the cocrystallization of proteins, precipitants and fragments directly
on X-ray data-collection media such as MiTeGen MicroMeshes. Crystal growth is driven by vapor diffusion against a
precipitant that is secured in a 1% agar matrix deposited into a
long ‘moat’ in the vicinity of the micromesh; placing the agar/
precipitant mixture is fast (15 min per tray) and easy to do.
The crystals can be seen through a ‘window’ of transparent
material on both sides of the micromesh that allows components such as purified protein, precipitant and chemicals
(including fragments and cryoprotectants) to be added to the
micromesh either before or after crystal formation. The
window is also transparent to X-rays, so that crystals can be
tested for diffraction properties while still in the box (the
entire assembly has a standard ANSI/SBS footprint and can
be handled by robotic plate scanners). In some cases, the agar
and precipitant were added to the window (instead of the
moat) to speed crystal formation by decreasing the distance
Acta Cryst. (2014). D70, 1177–1189

Figure 2
Pin platform box. In situ vapor-diffusion co-crystallization is carried out
in a pin platform box. All components are 3D printed (print files are
available on request from the authors). The pin platform (A) contains 96
sockets for securing micromeshes. The lid (B) isolates the pin platform to
prevent dehydration. The internal environment is governed by precipitant solution that is secured in 1% agar and is deposited into the moat
(C). The window (D) is used to view specimens, to add components
through apertures in the lid (E) and to remove excess mother liquor from
the micromesh via apertures in the bottom of the pin platform box (Fig.
6). The insets show a close-up view of the MiTeGen micromeshes above
the window (including pink precipitant) and a magnified view of the in
situ crystals. The distance between the agar in the moat and the meshes is
4 mm. The vapor-diffusion setup is equivalent to a sitting drop when the
pin platform box is right side up; the box is inverted to achieve a hangingdrop configuration.
Yin et al.
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Table 1
Crystallization, data-collection and model-refinement statistics.

Crystallization conditions
Strategy
Hanging drop
Protein (ml)
Precipitant (ml)
Fragment (ml)
In situ
Protein (nl)
Precipitant (nl)
Fragment (nl)
Protein
Hanging drop
In situ
Buffer
Hanging drop
In situ
Precipitant
Hanging drop
In situ

Lysozyme

Thermolysin

Trypsin

Stachydrine demethylase

4
4
2

2
2
1

4
4
2

2
2
1

20
20
10

1.25
1.25
2.5

20
20
10

5
5
2.5

120 mg ml1

330 mg ml1 + 45% DMSO

30 mg ml1 + 10 mg ml1 benzamidine

120 mg ml1

330 mg ml1 + 45% DMSO

30 mg ml1 + 10 mg ml1 benzamidine

10 mg ml1 + 25 mM
hexaamine CoCl2
10 mg ml1 + 25 mM
hexaamine CoCl2

0.1 M sodium acetate pH 4.6
0.1 M sodium acetate pH 4.6

50 mM Tris pH 7.5
50 mM Tris pH 7.5

10 mM CaCl2 + 20 mM HEPES pH 7
10 mM CaCl2 + 20 mM HEPES pH 7

0.1 M HEPES pH 7
0.1 M HEPES pH 7

4% NaCl

1.45 M CaCl2

4% NaCl

1.45 M CaCl2

20% PEG 8000 + 200 mM ammonium
sulfate + 100 mM bis-tris
20% PEG 8000 + 200 mM ammonium
sulfate + 100 mM bis-tris

7.5% PEG 3350
+ 10% glycerol
7.5% PEG 3350
+ 10% glycerol

NSLS X25
NSLS X12C
1.1
75  75
1.6 (31.6)
4.8 (43.2)
58.42 (6.32)
98.1 (96.6)
28.2

NSLS X25
NSLS X12C
1.1
50  50
1.4 (28.3)
3.6 (15.4)
46.31 (10.25)
99.7 (94.4)
5.9

NSLS X25
NSLS X25
1.1
50  50
2.3 (41.9)
7.9 (57.7)
26.5 (0.8)
91.6 (52.1)
18.2

43035
13.0/15.9

38155
11.95/14.31

21941
21.37/26.70

0.029
2.559

0.024
2.644

0.016
1.784

Data-collection statistics
X-ray source
Screening
NSLS X29
Confirmation
NSLS X12C
Wavelength (Å)
1.1
Beam size (mm)
75  75
Resolution (Å)
1.6 (39.2)
Rmerge (%)
11.4 (94.8)
hI/(I)i
14.9 (76.0)
Completeness (%)
99.2 (91.4)
Multiplicity
22.8
Model-refinement statistics
No. of reflections
14409
Rwork/Rfree (%)
17.29/20.89
R.m.s. deviations
Bond lengths (Å)
0.022
Bond angles ( )
2.096

conventional hanging-drop crystallization conditions for three
standard protein samples (lysozyme, thermolysin and trypsin)
and for a metalloprotein of interest (stachydrine demethylase;
Table 1). For each protein, the same precipitants that were
identified in the hanging-drop experiments were loaded into
the moat (for trypsin and stachydrine demethylase, in the
window) of the pin platform (held in place by a 1% agar
matrix). Each pin platform was prepared by maintaining a 2%
agar solution at 100 C until the agar transitioned into random
coil, and then combining the agar with equal parts of doubleconcentration precipitant1. The agar and precipitant solution
was then deposited into the moat (or window) of the pin
platform and allowed to solidify. The same conditions that
yielded crystals in a conventional hanging-drop experiment
were used to yield in situ crystals on X-ray data-collection
media mounted in a pin platform box. The pin platform box
that was used for in situ crystallization of lysozyme was re-used
1
Some precipitants may inhibit agarose-gel formation (for example, >2 M
salts and >50% PEGs). In these cases, the agarose gel is prepared without
precipitant and the precipitant is soaked into the gel afterwards. We
successfully used this solution with photosystem II crystals (the PS2 mother
liquor contains 40% PEG 5000 and agarose will not harden in its presence).

1180
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on different days; to avoid dehydration, the agar moat was
soaked in liquid precipitant solution until needed. For each
protein, up to 96 pin-mounted MiTeGen MicroMeshes were
snapped into the sockets of a pin platform, and then manually
adjusted until each micromesh was in the center of the
window.
A plate-specific definition that allows the Echo Array
Maker software (Labcyte Inc., Sunnyvale, California, USA) to
operate the Echo 550 and dispense liquids to 30 locations on
each of the 96 micromeshes is available on request from the
authors. This plate definition was made in two stages using
Echo Array Maker. Firstly, an array definition was generated
to access each of the 96 micromeshes on the pin platform.
Then, to allow sufficient granularity for the destination locations, the software was used to further partition each micromesh into ten rows by three columns of accessible destination
locations using 100 mm grid spacing. Initially, each transfer
template was tested for accuracy using water droplets, but this
procedure was suspended after gaining confidence in the
instrumentation.
After the pin platform had been loaded with agar and
precipitant, it was sealed by putting on the lid (Fig. 2). Each
Acta Cryst. (2014). D70, 1177–1189
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pin platform box assembly was inspected to ensure a snug fit
and a hermetic seal. In most cases, experimental components
(purified protein, precipitant and fragment) were added to
each micromesh through small (2 mm) apertures in the lid.
Apertures were manually fashioned on the lids using a heated
metallic probe with a 1 mm diameter (the lids with apertures
can be re-used for multiple co-crystallization experiments). To
quickly make apertures, we are developing a robotic holepuncher in collaboration with a research group that specializes
in automation. When not in use, the apertures were covered
with a thin strip of adhesive tape (the pin platform box is
airtight with the adhesive tape in place). Lysozyme and thermolysin crystals were resistant to desiccation and these fragment screens were concluded before we had perfected these
aperture transfer techniques. Cryoprotectant was integrated
with the precipitant solution for lysozyme, trypsin and
stachydrine demethylase. Thermolysin crystals were cryoprotected by adding 20% ethylene glycol through apertures after
the crystals had grown.
Dehydration was virtually eliminated by sealing the source
and destination plates, and transferring all liquids through
small apertures in the seal. In this study, trypsin and stachydrine demethylase were grown in situ with strict adherence
to transferring all components through apertures, so that
complete control of the environment was maintained at all
times. In contrast, aperture transfers were not used in the in
situ crystallization of lysozyme and thermolysin. Because the
use of apertures resulted in marked improvement in the
reproducibility and the quality of the crystals (see x3.1), we
conducted a side-by-side comparison of otherwise identically
prepared trypsin specimens in which components were
transferred through apertures in one case but not in the other
case (see x3.4). In addition to the apertures in the top of the
lid, apertures were also fashioned in the bottom of the pin
platform windows. These bottom apertures were used to wick
away excess mother liquor (when needed) using dental points
that were manually pushed upwards until they contacted the
bottom of the micromeshes (see x3.5).
Purified proteins, precipitants and fragments were
contained in one or more acoustically transparent 384-well
polypropylene source microplates (Labcyte Inc., Sunnyvale,
California, USA). In cases where dehydration was not a
significant factor (lysozyme and thermolysin), components
were added to each micromesh before the pin platform was
sealed with its lid. The best results were obtained when
specimens were prepared entirely through apertures because
this precludes any concentration changes owing to dehydration (trypsin and stachydrine demethylase) or hygroscopic
swelling (DMSO compounds). For example, thermolysin was
solvated in DMSO, which induced rapid hydration after the
liquid was transferred onto the micromesh. DMSO-solvated
fragments are expected to induce similar behavior.
Once the specimens were ready for X-ray data collection,
the lid was removed from the pin platform box and each
micromesh was manually inserted into a MiTeGen Reusable
Magnetic Cap and cryocooled by plunging into liquid nitrogen
(the reusable caps clamp the pins using a compression fitting,
Acta Cryst. (2014). D70, 1177–1189

with no adhesive necessary). We are developing a robotic
system to automate this step in collaboration with the aforementioned automation research group.
2.2. In situ co-crystallization of proteins with fragment
libraries

To demonstrate the capability of the Echo 550 to identify
novel ligands by co-crystallizing proteins with fragment
libraries in situ directly on data-collection media, we prepared
a ‘mini-library’ of compounds (solvated in water, DMSO or
ethanol) and co-crystallized these compounds with three
commercial test proteins (lysozyme, thermolysin and trypsin)
and with one expressed protein (stachydrine demethylase), as
described in x2.1. Some of the compounds were previously
reported ligands (N-acetylglucosamine, aspartic acid, benzamidine and l-proline), and others were unknowns. In all, our
fragment mini-library (including known ligands) consisted of
33 compounds (four in DMSO and one in 25% ethanol;
Supplementary Table S12). The compounds in our mini-library
were chosen largely because of safety guidelines, since our
workforce for this study was predominantly undergraduate
students in short-term appointments (spring and summer
terms of 2013). The mean mass of our mini-library (159 Da)
was similar to published best practices (268 Da) (values
obtained from ChemSpider; Pence & Williams, 2010).
However, the mean lipophilicity of our mini-library (2.08)
was lower than published best practices (2.10; Keserü &
Makara, 2009). Each protein was checked for DMSO
compatibility in two ways before beginning the study. Crystal
appearance and/or diffraction quality began to decay at a
DMSO concentration of 5% for lysozyme, 40% for thermolysin, 20% for trypsin and 10% for stachydrine demethylase.
In a typical experiment, 2.5 nl of each fragment was added to
10 nl of protein and precipitant. In the case of thermolysin,
smaller volumes were used (2.5 nl of protein and precipitant).
A freely accessible stop-motion video of a 2.5 nl drop of
thermolysin (330 mg ml1 thermolysin in 50 mM Tris pH 7.5,
45% DMSO, 1.4 M CaCl2) co-crystallized in situ with 2.5 nl
l-asparagine (300 mM) directly on a micromesh can be viewed
at http://www.youtube.com/channel/UCtCiMjlzBnq5VYZzrEi3EiQ/
videos. Crystallization conditions for all four proteins are
shown in Table 1. Note that in all cases the same conditions
that produced crystals on a conventional cover slip also
produced crystals directly on micromeshes.
Every co-crystallization micromesh (containing protein,
precipitant and fragment) was examined using a Leica
microscope. The micromeshes that contained crystals were
cryocooled by plunging into liquid nitrogen as described in
x2.1. Diffraction data were collected on beamlines X12C, X25
and X29 at the National Synchrotron Light Source (NSLS).
Data sets were processed with HKL-2000 (Otwinowski et al.,
2001) and further processed using CTRUNCATE in the CCP4
suite (Winn et al., 2011). Structures were obtained by molecular substitution from published models and refined using
2
Supporting information has been deposited in the IUCr electronic archive
(Reference: NJ5173).
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REFMAC (Murshudov et al., 2011) and ARP/wARP [Perrakis
et al., 2001; the starting models were PDB entries 1lyz for
lysozyme (Diamond, 1974), 4tln for thermolysin (Holmes &
Matthews, 1981), 4i8g for trypsin (Liebschner et al., 2013) and
3vca for stachydrine demethylase (Daughtry et al., 2012)].
Binding fragments were identified in an Fo  Fc difference
map by visual inspection. A computer algorithm was used to
confirm the binding and to compute the best occupancy
(PHENIX; Adams et al., 2010). We then used AutoDock Vina
(Trott & Olson, 2010) to compare each fragment that was
observed to bind in the co-crystallization experiments with the
best predicted pose for the same fragment (see Supporting
Information).
2.3. Multiple in situ protein plus fragment assays on one
data-collection support

The reported techniques can rapidly prepare specimens for
X-ray-based fragment hit discovery projects, and modern
synchrotrons can generate a complete data set in under 1 s
(Hodgson et al., 2009). Conversely, the duty cycle of existing
cryogenic automounters limits the maximum achievable
throughput to about one screened structure per minute. One
approach to circumvent this speed limit is to position multiple
discrete fragment co-crystallization experiments onto each
data-collection micromesh. To this end, MiTeGen collaborated with our group to design high-density micromeshes with
a capacity to accomodate as many as ten discrete experiments
(Fig. 4). To test these high-density formats, we used the high
‘drop-on-drop’ positional precision of the Echo 550 to cocrystallize 10 nl thermolysin (as described in x2.2) combined
with 10 nl 100 mM l-histidine and, separately, with 10 nl
100 mM l-asparagine. A fragment-free control was also
positioned on the same micromesh. All three co-crystals
yielded interpretable diffraction. A freely accessible stopmotion video tracks these crystals as they grow in the three
conditions, and can be viewed at the URL given in x2.2.

3. Results
All of the data reported in this study were collected from
co-crystallization experiments with the fragment mini-library.
However, it is also possible to grow native crystals in situ on
data-collection micromeshes and then acoustically combine
the already grown crystals with the fragment library. To
explore this possibility, we compared the results obtained by
in situ co-crystallization of thermolysin with a fragment minilibrary with the results obtained when native in situ crystals
were soaked overnight in the presence of the same fragments
(data not shown). Although the results were broadly similar,
in one case the same fragment was observed to bind in
a different conformation and location depending on the
technique used. Soaking and co-crystallization strategies are
complementary, and often yield different false negatives.
Soaking may overlook binding sites that are occluded
by interprotein contacts, and co-crystallization may disturb
the chemical environment and prevent crystal growth.
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Consequently, users of the in situ co-crystallization technique
are advised to be aware that the binding properties of fragment hits discovered through co-crystallization may differ
from the binding properties of fragment hits discovered
through soaking experiments.
3.1. In situ crystallization conditions are similar to hanging
drops

In a conventional crystallization experiment, when the
working volume falls below a few hundred nanolitres differences often arise in the composition and concentration of
precipitants that are needed to induce crystallization. We did
not observe this trend when comparing our hanging-drop and
in situ crystallization experiments for test crystals (Table 1).
We believe the underlying cause of the reported variations
between crystallization conditions at nanolitre versus microlitre volumes is largely because very small droplets are
susceptible to dehydration (with some liquid-handling
methods, the uncertainty in the volume transferred will also
increase with small volumes). Using in situ crystallization, this
variation can be prevented by strict adherence to transferring
all liquids through an aperture (from a sealed 384-well polypropylene source microplate and into a sealed pin platform
box which has reached equilibrium with its precipitant solution). Table 1 illustrates that careful avoidance of dehydration
(by monitoring susceptibility and using aperture transfers
when necessary) yields identical crystallization conditions
for conventional hanging-drop experiments compared with
acoustically prepared in situ experiments.
3.2. In situ co-crystallization experiments yield high-quality
data and identify fragment hits

The reservoir of the pin platform box is a shared precipitant
that drives the crystallization of up to 96 protein plus fragment
trials in the box. This design accelerates specimen preparation,
but precludes tuning the precipitant mixture for each fragment. For each test protein, a binary yes/no summary for
chemicals that were compatible with the shared crystallization
solution is shown in Supplementary Table S1 (crystallization is
denoted by an X; binding is denoted by the occupancy). Our
results are encouraging because despite using very high
concentrations of fragments (usually 100 mM; see Supplementary Table S1), most of the co-crystallization trials yielded
high-quality crystals that generated good diffraction data and
interpretable electron density. This supports the feasibility of
using a shared reservoir to unambiguously determine a yes/no
answer for the success of most co-crystallization trials.
For each of the proteins examined, co-crystallization trials
against our mini-library revealed one previously unreported
fragment hit. All of these hits were confirmed by conventional
hanging-drop follow-up experiments. For lysozyme and thermolysin, the hanging-drop experiments yielded larger and
better diffracting crystals, and these data were deposited in the
PDB. In the case of trypsin, the original screening crystal
yielded the best data. The stachydrine demethylase data are
being deposited in combination with a separate manuscript.
Acta Cryst. (2014). D70, 1177–1189
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The known ligand was also confirmed in each protein. Fig. 3
summarizes the outcome for the highest occupancy binding
observed in each case.
3.2.1. Lysozyme. Lysozyme crystallization was resistant to
desiccation, so protein, precipitant and fragments were added
to an open pin platform box and the cover was fitted after all
components had been added. In situ lysozyme crystals formed
in thin layers that were suitable for data collection without
removing excess mother liquor. Three of the compounds
tested in our mini-library were incompatible with the crystallization procedure. The known N-acetylglucosamine ligand
was easily identified in the electron density. Benzamidine was

also observed to bind to lysozyme, a previously unreported
result (PDB entry 4n8z). The top scoring pose in a simulation
using AutoDock Vina correctly positioned benzamidine in the
same location and orientation as observed in the electron
density (0.21 Å average coordinate error; see Supplementary
Table S2).
3.2.2. Thermolysin. Once thermolysin crystals were
observed on the micromeshes, cryoprotectants were added to
each crystal. The thermolysin crystallization solution is highly
hygroscopic. Consequently, the aggregate volume on these
micromeshes was excessive, which caused unacceptable
background in the X-ray diffraction. To address this problem,

Figure 3
In situ crystallization and fragment hit discovery directly on micromeshes. The pictures on the left show crystals grown in situ on the micromeshes. The
pictures in the middle show electron density around known ligands (OMIT difference contoured at 3) that were co-crystallized with protein
(N-acetylglucosamine with lysozyme, l-aspartic acid with thermolysin, benzamidine with trypsin and l-proline with stachydrine demethylase). The
pictures on the right show electron density around previously unreported fragment hits that were discovered using in situ co-crystallization (benzamidine
with lysozyme, l-asparagine with thermolysin and imidazole with trypsin) and one unreported fragment (cleaved N-methylproline) that was previously
discovered by one of the authors (see x3.2). Note that the methyl moiety of N-methylproline is immediately cleaved in response to X-ray photoactivation
of the enzyme (because of this, the methyl moiety is not shown in the figure). PDB codes are indicated for deposited structures.
Acta Cryst. (2014). D70, 1177–1189
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each thermolysin micromesh was dab-dried using a ‘dental
point’ (Gutta Percha #13985) through an aperture at the
bottom of the pin platform window. Using X-ray data, binding
was observed both for the known ligand (aspartic acid) and for
a previously unreported test fragment (asparagine; PDB entry
4m65). The binding location and binding geometry observed
using the X-ray data were the same for aspartic acid and for
asparagine. However, the best predicted binding pose (the
top-scoring AutoDock Vina pose) had a slightly different
binding geometry (1.15 Å coordinate error; see Supplementary Table S2).
3.2.3. Trypsin. Because trypsin crystallization was very
sensitive to desiccation, all transfers of protein, precipitant
and fragments were carried out through apertures in the pin
platform box cover. As a consequence, the results obtained
from trypsin crystals were markedly more reproducible than
the results obtained from lysozyme and thermolysin crystals.
The overall quality of the trypsin crystals, as well as the
observed X-ray diffraction patterns, was also superior. The
crystals diffracted to 1.1 Å resolution and consequently no
follow-up experiment was needed to produce publicationquality data for benzamidine (a known control) or imidazole
(a previously unreported allosteric binding mode that is
distant from the active site; PDB entry 4ncy). Imidazole
binding caused significant conformational changes in the
surrounding region of the protein (Supplementary Fig. S2). To
demonstrate the utility of in situ fragment screening, all 33
X-ray data sets from the trypsin co-crystallization with our
mini-library were used to generate refined structures (see
x2.2). Data from this first-pass co-crystallization trial are
shown in Supplementary Fig. S1). A picture of the crystal and
a rendition of the resulting electron density (difference OMIT
map contoured at 3) are shown for (i) the known benzamidine ligand in the best diffracting no-hit screen, (ii) the known
benzamidine ligand in the worst diffracting no-hit screen and
(iii) the previously unreported imidazole ligand. The two topscoring AutoDock Vina poses reproduced the observed
binding location (0.78 Å average coordinate error), but the
rings were rotated by 72 to accommodate two binding
geometries with equal energies (see Supplementary Table S2).
Trypsin was one of the targets of the SAMPL challenge for
identifying ligand hits to support modelling work (Newman
et al., 2009), so a very large number of trypsin ligands are
reported in the PDB. Our follow-up experiments reproduced
the two previously reported imidazole binding locations (PDB
entries 3qk1 and 1y59; Schopfel et al., 2011; Di Fenza et al.,
2007).
3.2.4. Stachydrine demethylase. Initially, in situ crystallization of stachydrine demethylase was a challenge. After
multiple attempts at crystallization, it was clear that desiccation was driving irreproducibility because the crystallization
results were sensitive to the order in which the specimens were
prepared. The first specimens to be prepared failed to crystallize because they dehydrated during the time needed to
prepare the later specimens. To overcome the stubborn irreproducibility, the experiments had to be repeated with strict
adherence to transferring all specimens through apertures.
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Once this had been performed, we were able to reproduce
results previously demonstrated by our group (Agarwal et al.,
2014). When l-proline was co-crystallized with stachydrine
demethylase, the l-proline was observed in the electron
density. In contrast, when N-methylproline was co-crystallized
with stachydrine demethylase, only l-proline was observed in
the electron density (electron density was not observed for the
methyl moiety). This supports the hypothesis that exposure to
X-rays quickly induces enzymatic cleavage of the N-methyl
group, leaving behind l-proline.
3.3. One protein co-crystallized against three discrete
fragments on one high-density micromesh confirms multiple
fragment hits

To fully utilize the available brightness of modern
synchrotron sources, specimens will have to be delivered to
the X-ray beam much faster than the duty cycle of cryogenic
automounters. Although the majority of the data for this study
were generated using a traditional ‘one experiment per
micromesh’ concept, we also tested the feasibility of using
high-density specimen supports so that data-acquisition rates
could exceed the duty cycle of the mounting system. We
demonstrated that three distinct protein plus fragment
co-crystallization trials could be co-positioned on a single
micromesh. Moreover, the physical space on the high-density
micromesh is adequate to support up to ten experiments of
this type (Fig. 4). The implied sustained throughput is 600
fragments screened per hour. This throughput approaches the
maximum data-acquisition rate that can be supported by the
available X-ray brightness of best-in-class third-generation
synchrotrons using a 20  20 mm beam size.
3.4. Transferring components through apertures to prevent
desiccation

Many groups have observed instability in the composition
and concentration of the precipitants needed as crystallization
volumes fall below 100 nl. This may be caused by desiccation
in non-microfluidic micro-crystallization techniques (Totir
et al., 2012). Exposure to the uncontrolled laboratory atmosphere is expected to impact small volumes (in the few
nanolitres range) much more rapidly than larger volumes (in
the few microlitres range). To test this hypothesis, we simulated a side-by-side comparison of 96 co-crystallization trials
with and without the use of apertures. The simulation
consisted of ten in situ co-crystallization trials (each with one
fragment screen). Each co-crystallization trial was separated
by ten two-component transfers to a dummy location, to
simulate the total time that would be required for a genuine
96-well preparation (Fig. 5). Our results demonstrate that
preventing desiccation by transferring all components through
apertures is the defining factor that determines the success of
the experimental protocol. When trypsin specimens were
prepared using apertures, the experiment was successful.
However, when apertures were not used, the protein either
precipitated or formed small low-quality crystal clusters.
Improvements in crystal growth were also observed when
Acta Cryst. (2014). D70, 1177–1189
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stachydrine demethylase co-crystallization was performed
using apertures.
3.5. Removing excess mother liquor to improve the signal-tonoise ratio

In situ crystallization of thermolysin resulted in well
diffracting crystals surrounded by a swollen envelope of
mother liquor. The excess mother liquor consisted of protein
solution, precipitant solution, fragment solution and water
that was incorporated owing to the hygroscopic properties of
DMSO. To improve the signal to noise, excess mother liquor

Figure 4
Placing multiple experiments on a single specimen holder allows the
goniometer to act as an ‘auxiliary robotic automounter’ that rapidly
translates between experiments during the time that the conventional
cryogenic automounter completes its duty cycle. (a) shows in situ cocrystallization of thermolysin, precipitant, cryoprotectant and fragments.
In this example the fragments were asparagine (bottom), histidine
(middle) and a control with no ligand (top). The custom specimen holder
has sufficient space to accommodate ten discrete experiments (b) (with
no ligands or cryoprotectants). Even with such a high density of
specimens, the spacing between droplets is adequate to prevent crosscontamination (inset). A video is available on our website showing
multiple crystals growing in situ directly on custom MiTeGen paddles,
each with a different fragment (URL in x2.2).
Acta Cryst. (2014). D70, 1177–1189

was removed by thrusting dental points upwards through an
aperture in the bottom of the window and vertically up to the
bottom of each mesh. The absorbent points then steadily
removed the excess mother liquor through the micromesh
grid, leaving the protein crystals unharmed and surrounded by
a thin blanket of mother liquor. This procedure was highly
effective (Fig. 6), and in hindsight could also have benefited
the quality of the other three in situ crystallization efforts.

4. Discussion
Fragment screening using X-ray crystallography immediately
links the fragment hit discovery step to powerful structural
tools such as competence for allosteric detection, bindingmode determination and insights for improving the characteristics of the candidate drug, such as pharmacokinetics
(Blundell & Patel, 2004). Supplementary Fig. S2 illustrates a
significant conformational adaptation of trypsin in response to
allosteric binding of an imidazole fragment. This highlights the
promise of in situ co-crystallization to uncover novel therapeutic compounds that modify the structure and/or function
of health-related macromolecules.
One major limitation of using X-ray crystallography as the
primary screening tool is that data-collection rates impose an
upper limit to the attainable screening speed. However, the
very high brilliance of third-generation synchrotrons can
mitigate this limit with the assistance of suitable technologies
for rapidly preparing and delivering specimens to the X-ray
beam. Acoustic droplet ejection is a robust technology for
rapidly preparing protein crystals and for rapidly delivering
protein crystals to the X-ray beam, either on micromeshes
(Soares et al., 2011) or on a moving conveyor belt (Roessler et
al., 2013).
We have demonstrated that acoustic methods enable fragment screening using very low volumes of protein and fragment (2.5 nl) at a high speed of specimen preparation (60
specimens per minute) and with rapid data acquisition (ten
data sets per minute). This acoustic strategy for in situ cocrystallization directly on data-collection media is remotecompatible and can potentially deposit machine-generated
metadata directly into a universal database. The high
throughput enables screening highly concentrated (100 mM)
fragments one at a time, and avoids chemical cocktails and
inter-fragment reactivity (Hubbard, 2008) and the danger that
a high aggregate fragment concentration may interfere in
protein or crystal integrity (Shrake & Ross, 1990; Chi et al.,
2003). We identified a total of three unreported fragment hits,
one for each test protein, by screening against a 33-component
fragment mini-library. The average occupancy was 80%. These
data suggest that acoustic in situ co-crystallization of proteins
and fragments directly on micromeshes is a vigorous and
effective strategy for lead discovery and drug development.
Surface plasmon resonance (SPR) is a conventional strategy
for analysis of interactions with and between macromolecules
used for active-site independent screening of fragment
libraries in drug discovery, where proteins are tethered to a
gold chip (Myszka & Rich, 2000). Along with X-ray
Yin et al.
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crystallography, SPR can identify allosteric compounds
(Vanderpool et al., 2009), and the two methods yield
complementary information about fragment hits (kinetics
from SPR, binding orientation from crystallography). SPR
search strategies involve careful pre-preparation of each gold
chip, individually tailored to each protein, to perfect the
protein-tethering strategy and the pilot screen controls (Löfås
& McWhirter, 2006); this process typically depletes 5 mg from
the supply of purified protein (Giannetti, 2011; Rich &
Myszka, 2004). A systematic analysis for the SAMPL challenge required about one week to screen 384 samples,
including data analysis (Newman et al., 2012). Higher
throughput rates are achieved using multiple gold chips or

using pintool spotting (Neumann et al., 2007). Specimen
consumption is estimated as 100 ng of purified protein and
25 mg of fragment chemicals per screened condition. Sensitivity is high (1 mM; Myszka & Rich, 2000); however, both
false positives and false negatives are difficult to detect
without time-consuming confirmation experiments (Giannetti,
2011). SPR and the fast compact serial crystallography
described here are synergistic methods for fragment screening,
both because they yield complementary information (kinetics
and pose) and because each method can identify false positives generated by the other.
Regulatory therapeutic compounds often interact with the
target protein away from the active site (Sijbesma & Nolte,

Figure 5
Side-by-side comparison of trypsin in situ co-crystallization, with ejections made with and without apertures in separate experiments that simulate the
screening of 96 different fragments. Each panel shows a close-up view of a micromesh containing the same protein, precipitant and fragment.
Micromeshes prepared without the use of apertures are shown on the left and micromeshes prepared with the use of apertures are shown on the right.
Dehydration, precipitation and low-quality crystal formation were observed when apertures were not used (examples of each failure mode are shown at
different stages of the crystallization process). In contrast, the samples that were prepared using apertures did not show dehydration damage. The
samples that precipitated immediately after the ejections (a, left) did not improve with time. Three samples are shown: (a) protein, precipitant and
d-trehalose, (b) protein and precipitant control and (c) protein, precipitant and l-arabinose. In all three cases, the defining characteristic of successful cocrystallization for these trypsin screens was rigorous control of the environment to prevent desiccation.
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1991). Hence, a remaining challenge for fragment-based drug
discovery is a strong strategy for identifying allosteric pharmaceuticals to treat nonpathogenic diseases such as genetic,
degenerative and cognitive deficit disorders (Harms et al.,
2013). Structure-based drug discovery is competent to identify
such alternative binding sites; however, it has been limited by
challenging specimen preparation, sluggish data acquisition,
a difficult to automate crystal-mounting step and high
consumption of both purified protein and chemicals. To
overcome these challenges, we have developed a fragmentscreening method using in situ co-crystallization of proteins
and fragments directly on data-collection micromeshes. The
process is extraordinarily parsimonious for purified protein
(2.5–25 nl per screen) and chemical libraries (2.5 nl per fragment). The speed of specimen preparation (60 per minute)
and data acquisition (ten per minute) can keep up with the
high flux of third-generation synchrotrons. The Echo 550
automatically generates metadata, and this information can be

made available to the data-acquisition software. Finally, since
the crystals are grown in situ, we have eliminated the
specimen-mounting step, along with possible cross-contamination, crystal losses, dehydration and mechanical damage to
the crystals, all of which may occur during mounting. One key
remaining challenge, currently under development by our
collaborators, is the design of a simple robotic solution for
cryo-plunging pins and inserting them into cryogenic pucks.
Any sober evaluation of the potential offered by novel
drug-discovery processes must consider that promising
answers to this challenge have frequently encountered unexpected roadblocks. One frequent unwelcome guest has been
the cryptic false positive, which is revealed by extensive
additional investigation. This problem is somewhat mitigated
by structure-based methods, since inspection of the electrondensity map usually differentiates clear binders from marginal
cases. Other techniques are highly sensitive to small errors in
concentration, incorrect setup, inadequate controls or are
limited to certain classes of
proteins (for example, some
methods are incompatible with
membrane proteins or very large
proteins). In contrast, in situ
structure-based methods are
robust enough that the majority
of the specimen preparation was
carried out by undergraduate
students during a ten-week
summer internship. This new
technology promises hope for
identifying allosteric drugs to
treat disorders that have been
inaccessible to structure-based
drug discovery owing to low
protein expression, constraints
to fragment-search strategy or
insufficient throughput speed.

Figure 6
Dab-drying thermolysin crystals that were co-crystallized in situ. The thermolysin crystals grew well, but
were enveloped by excess mother liquor consisting of buffer solution, precipitant solution, fragment
solution and water that was incorporated owing to the hygroscopic nature of DMSO (DMSO is present in
both the thermolysin crystallization condition and the solvated fragments). For demonstration purposes, we
prepared a specimen with a hugely exaggerated volume of water-engorged DMSO. To improve the signal to
noise, each crystal-containing micromesh was individually dab-dried by thrusting an absorbent dental point
vertically upwards through an aperture in the bottom of the pin platform box window (a) (the vertical
absorbent point appears inclined owing to angular optics in the dissecting microscope). The absorbent point
then touched the bottom of the micromesh (b) and excess mother liquor was steadily withdrawn through
the holes in the micromesh (c), leaving the crystals surrounded by a thin blanket of mother liquor (d).
Crystals that had excess mother liquor withdrawn in this way were compared with untreated crystals. The
diffraction limit at unity I/(I) was observed to be 1.9 Å for dab-dried crystals versus 3.7 Å for untreated
crystals (data not shown).
Acta Cryst. (2014). D70, 1177–1189
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